| Ytd | -52.71% | |
| 1y | -49.41% |
| Open | 8.59 | Prev Close | 8.59 | Low | 8.57 | High | 8.68 | Mkt Cap | 1.99B |
| Vol | 151.15K | Avg Vol | 4.59M | EPS | 0.70 | P/E | 12.27 | Forward P/E | 10.50 |
| Beta | 0.73 | Short Ratio | 6.48 | Inst. Own | 93.59% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-05 | 50-d Avg | 8.46 | 200-d Avg | 13.58 | 1yr Est | 17.00 |
NEW YORK, July 22, 2026 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP, a nationally acclaimed investor
NEW YORK, July 22, 2026 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP a
NEW YORK and NEW ORLEANS, July 21, 2026 (GLOBE NEWSWIRE) -- Kahn Swick & Foti, LLC (“KSF”) and KSF p
The latest trading day saw Adma Biologics (ADMA) settling at $8.59, representing a -1.83% change fro
New York, New York--(Newsfile Corp. - July 21, 2026) - WHY: Rosen Law Firm, a global investor rights
NEW YORK, July 21, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has
ADMA Biologics, Inc. (ADMA) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud La
BENSALEM, Pa., July 21, 2026 /PRNewswire/ -- The Law Offices of Howard G.
LOS ANGELES, July 21, 2026 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises ADMA Biologics, Inc., (“
Wall Street's reassessment of ADMA Biologics accelerated after a short-seller report alleged that th
NEW YORK, July 21, 2026 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholde
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suff
A securities fraud class action lawsuit has been filed on behalf of ADMA Biologics investors after i
SAN DIEGO, July 20, 2026 (GLOBE NEWSWIRE) -- The law firm of Robbins Geller Rudman & Dowd LLP announ
New York, New York and New Orleans, Louisiana--(Newsfile Corp. - July 20, 2026) - Kahn Swick & Foti,
New York, New York--(Newsfile Corp. - July 20, 2026) - WHY: Rosen Law Firm, a global investor rights
LOS ANGELES, July 20, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm , a national shareholder rights l
New York, New York--(Newsfile Corp. - July 20, 2026) - Bronstein, Gewirtz and Grossman, LLC, a natio
NEW YORK, July 20, 2026 (GLOBE NEWSWIRE) -- Bronstein, Gewirtz & Grossman, LLC, a nationally recogni
ADMA Biologics' SEC filings allegedly used boilerplate risk language and selective related party dis
NEW YORK, July 20, 2026 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP a
LOS ANGELES, July 20, 2026 /PRNewswire/ -- The DJS Law Group reminds investors of a class action law
ADMA Investors Have Opportunity to Lead ADMA Biologics, Inc. Securities Fraud Lawsuit with the Schal
LOS ANGELES, July 20, 2026 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litiga
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suff
NEW YORK, July 19, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm,
New York, New York--(Newsfile Corp. - July 18, 2026) - WHY: Rosen Law Firm, a global investor rights
ADMA Deadline: ADMA Investors Have Opportunity to Lead ADMA Biologics, Inc. Securities Fraud Lawsuit
ADMA Biologics, Inc. Notice of August 10, 2026 Application Deadline for Class Action Lawsuit - Conta
NEW YORK, July 17, 2026 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, rem
/PRNewswire/ -- Kahn Swick and Foti, LLC ("KSF") and KSF partner, former Attorney General of Louisia
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suff
New York, New York and New Orleans, Louisiana--(Newsfile Corp. - July 17, 2026) - Kahn Swick & Foti,
LOS ANGELES, July 17, 2026 (GLOBE NEWSWIRE) -- Glancy Prongay Wolke & Rotter LLP reminds investors o
SAN DIEGO--(BUSINESS WIRE)---- $ADMA #Biopharmaceutical--Robbins LLP reminds stockholders that a cla
NEW YORK, July 17, 2026 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareh
NEW YORK, July 17, 2026 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP a
SAN DIEGO, July 17, 2026 /PRNewswire/ -- Robbins Geller Rudman & Dowd LLP announces that purchasers
San Diego, California--(Newsfile Corp. - July 16, 2026) - Robbins Geller Rudman & Dowd LLP announces
NEW YORK, July 16, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm,
PHILADELPHIA, July 16, 2026 /PRNewswire/ -- National plaintiffs' law firm Berger Montague PC announc
New York, New York--(Newsfile Corp. - July 16, 2026) - Bronstein, Gewirtz and Grossman, LLC, a natio
New class action for ADMA Biologics (ADMA) urges investors to seek recovery for alleged securities f
NEW ORLEANS, July 16, 2026 (GLOBE NEWSWIRE) -- ClaimsFiler, a FREE shareholder information service,
ADMA Biologics allegedly certified internal controls as effective while concealing channel stuffing
NEW YORK, July 16, 2026 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been
NEW YORK, July 16, 2026 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP announces that a shareholder has
NEW YORK--(BUSINESS WIRE)---- $ADMA #ADMA--ADMA Biologics Investors are Reminded to Contact BFA Law
LOS ANGELES, July 15, 2026 /PRNewswire/ -- Glancy Prongay Wolke & Rotter LLP announces that investor
Mizuho analyst Anthony Petrone maintains ADMA Biologics (NASDAQ:ADMA) with a Outperform and lower